Khosla Ventures

Khosla Ventures, founded in 2004 and headquartered in Menlo Park, California, is a venture capital firm that provides strategic advice, capital, and support to bold entrepreneurs across various sectors. The firm focuses on early-stage investments in areas such as artificial intelligence, climate technology, sustainability, enterprise solutions, consumer products, fintech, digital health, medical technology, and therapeutics. Khosla Ventures is particularly interested in innovative solutions that address significant socio-economic challenges and enhance productivity, especially for low-income populations and small businesses in emerging markets. The firm embraces experimentation and is open to investing in unconventional and high-risk ventures, often acting as the sole investor in groundbreaking projects. With a commitment to fostering impactful entrepreneurship, Khosla Ventures seeks to create value through technological advancements and creative business models, with a special emphasis on markets in South Asia.

Bruce Armstrong

Partner

Alex Bentley

Partner and Investor

Blignaut, Ryno

Operating Partner

Alice Brooks

Principal

Peter Buckland

General Partner and COO

Byun, Brian

Venture Partner

Catherine Casuga

Operating Partner

Jon Chu

Partner and Investor

Ece Erdagoz

Principal

Bryan Gartner

Partner

Kanu Gulati

Partner

Judy Huang

Operating Partner

Khosla, Vinod

Managing Director

Kelly Kinnard

Operating Partner

Alexander Morgan

Partner

Arash Rebek JD

Partner, Capital Formation

Jessy Rivest

Partner and Investor

Scanlan, Leah

Operating Partner

Nikita Shamgunov

Partner

Sven Strohband Ph.D

Managing Director

Rajesh Swaminathan

Partner

David Weiden

Managing Director

Ece Wyrick

Principal and Investor

Adam Coates Ph.D

Operating Partner

Kanupriya Gulati Ph.D

Partner and Investor

Past deals in Series A

Regie.ai

Series A in 2023
Regie.ai develops an AI-powered sales engagement platform that automates outbound prospecting and enhances workflow efficiency. The company's platform, RegieOne, integrates sales engagement, parallel dialing, enrichment, and intent data, providing operations teams with a centralized view of their processes

Genecis

Series A in 2022
Genecis is an early-stage organic waste processing startup that uses biotechnology to convert waste into biodegradable plastics and other high-value materials. It converts organic waste into PHA (Polyhydroxyalkanoate), a biodegradable, compostable, and non-toxic polymer that can be tuned to replace a wide variety of traditional plastics. PHA can be used for single-use plastics, clothing and textiles, automotive interiors, medical tools and products, and food contact applications.

Traba

Series A in 2022
Traba is building a world where the global supply chain operates at peak efficiency. We connect industrial businesses with reliable workers to fill open shifts and empower both businesses and workers to reach their full productivity and potential.

CHARM Therapeutics

Series A in 2022
CHARM Therapeutics delivers transformational medicines through 3D deep learning and cutting-edge drug discovery technologies. It delivers transformational medicines through 3D deep learning and cutting-edge drug discovery technologies to help doctors in treating undruggable disease targets.

Anagenex

Series A in 2022
Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.

Nitricity

Venture Round in 2022
Nitricity is an energy company that creates renewable nitrogen fertilizer production with zero carbon emissions.

Nomagic

Series A in 2022
Nomagic provides smart pick and place robotic solutions for order fulfillment. Their solutions bring efficiency, flexibility and reliability to e-commerce warehouses. They automate tedious tasks while reducing the cost of fulfillment and allow warehouses to face shortage of labor and scale easily to 24/7 operations. Nomagic's first robots are on packing lines at Cdiscount, the #1 French eCommerce platform.

Adyton PBC

Venture Round in 2022
Experience the brilliance of getting the basics right with AOK. The Adyton Operations Kit is secure mobile software for mission-critical work. AOK is built for the warfighter in mind, allowing secure access on-the-go, while also generating data for the enterprise.

VitroLabs

Series A in 2022
VitroLabs is a startup working on the cutting edge of 3D tissue engineering using stem cell-based technologies. The company develops a fully scalable tissue engineering platform combining the latest breakthroughs in stem cell research and biomaterials. It manufactures real leather without the need to raise and slaughter animals using breakthroughs in stem cell research and tissue engineering. VitroLabs was founded on 2016 and is based in San Jose, California.

Primer

Series A in 2022
At Primer Microschools, students learn at their own pace, pursue their passions, and get the support they deserve. A school designed for tomorrow's leaders, enrolling today.

Leaft Foods

Series A in 2022
Leaft Foods exists to reduce the environmental impact of food production. We capture the most plentiful protein on the planet, Rubisco from green leaves.

Tarana Wireless

Venture Round in 2022
Tarana Wireless™ has pioneered a carrier-class universal wireless transport solution that is a breakthrough innovation with deterministic True NLOS performance, ubiquitous coverage, multi-kilometer range, industry-leading spectral efficiency, unprecedented capacity and scalability, zero-touch operation, and considerably lower total cost of ownership. It has the flexibility to be deployed for a wide range of applications including small cell backhaul, last mile fiber extension, tactical mobile operations, and more. Visit www.TaranaWireless.com for additional information.

Cor

Series A in 2022
COR helps you implement globally-proven healthy lifestyle practices, then shows you a totally new type of data about how your body responds. Optimize your lifestyle and discover the impact of different daily customs with precise, science-based self-knowledge.

Ava

Series A in 2022
Ava develops a live captioning platform that uses AI to transcribe what people say. It is committed to total accessibility for the 466M deaf/hh worldwide.

Volta Labs

Series A in 2022
Volta Labs is a biotechnology company that develops scalable automation for genetic engineering.

Aether Diamonds

Series A in 2022
Aether Diamonds produces the world's first and only diamonds made 100% from captured carbon. Certified B Corp. 2022 Fast Company Top 10 Most Innovative Consumer Goods Companies. 2022 "Best for the World" B Corp.

Emi Labs

Series A in 2022
At Emi we are on a mission to increase Frontline Workers’ access to professional opportunities. This is a population that accounts for +70% of the world’s workforce. They are digitally invisible, as there’s little to no data available on who they are, their career history, or their skill set, limiting their access to professional opportunities and growth. We're here to transform this by building the infrastructure to make Frontline Workers visible. Our first step to achieving our mission is to transform the recruiting experience into an easy, human and fair process, for both candidates and companies with high-volume job openings. Emi, our main product, is an A.I. recruitment assistant that enables companies to engage in a conversation with each applicant to detect interested and qualified individuals while saving Recruiters a huge amount of time by automating tasks such as screening, validating skills, scheduling interviews, and collecting documents. We operate with a remote-first culture with office hubs in Buenos Aires, Mexico City, and San Francisco.

WorkWhile

Series A in 2022
WorkWhile is an hourly labor technology platform that connects workers with shifts in various industries like warehouse, light industrial, last-mile delivery, hospitality, food production, and event services. It uses cognitive science and behavioral analysis to match workers to jobs that fit their skills, schedule, and location. The platform supports workers with perks like next-day pay and sick leave credits. WorkWhile was founded in 2017 by Amol Jain and Jarah Euston and is based in San Francisco, California.

Verdagy

Series A in 2022
Verdagy is revolutionizing water electrolysis technology to facilitate large-scale green hydrogen production. Their solution achieves the lowest upfront capital costs and offers a competitive unit economics for production. Located in Moss Landing, California, Verdagy operates laboratory and pilot plant facilities to advance and rapidly scale its technology platform.

LEX Markets

Series A in 2022
LEX Markets is a commercial real estate securities marketplace that takes commercial buildings public through single-asset IPOs. It enables both accredited and non-accredited investors to buy and sell shares of individual commercial real estate assets without lockups, starting at $250. The company's platform is powered by Nasdaq to offer the same robust, low latency, and high-performance trading features used by 70+ global markets around the world. The company was founded in 2018 and is headquartered in New York.

Cellino

Series A in 2022
Cellino is building a scalable, automated biomanufacturing system for potentially curative personalized cell therapies. Cellino’s vision is to enable healthier lives worldwide with personalized treatments derived from induced pluripotent stem cells (iPSCs), which can serve as the basis for therapies for a host of chronic degenerative diseases, including vision loss and Parkinson's disease.

Azibo

Series A in 2022
Azibo is a financial services platform for rental properties that provides solutions for rent collection, banking, lending, and insurance. The company was founded in 2018 and is headquartered in Reno, Nevada.

Fountain Therapeutics

Series A in 2021
Fountain Therapeutics, Inc. is a biotechnology company focused on developing treatments for age-related diseases. Founded in 2018 and based in San Francisco, California, the company aims to create a future where individuals live healthier for longer. It employs a transformative cellular model that mimics the complex characteristics of aging within a laboratory setting. By integrating this model with advanced artificial intelligence and computer vision, Fountain Therapeutics seeks to establish an innovative platform for identifying novel therapeutic targets. This approach is designed to facilitate the development of effective treatments for diseases associated with aging, ultimately aiming to reverse cellular aging and improve health outcomes.

Mimica Automation

Series A in 2021
Mimica watches you work and learns to automate your most repetitive tasks. Its research and tech are backed by Entrepreneur First, Europe's most successful accelerator and seed fund.

Splash

Series A in 2021
Splash develops AI-powered video games that lets anyone create and perform music to live audiences inside virtual venues.

Supplant

Series A in 2021
Supplant is a biotechnology platform working in the food sector. It develops natural food ingredients from agricultural resources to allow food manufacturers to decrease sugar, increase fiber, and boost the gut health-promoting qualities of its products.

Loop

Series A in 2021
By using data, technology, and high quality medical expertise, we aim to deliver an empathetic people-centric healthcare experience that helps people live longer.

Loyal

Series A in 2021
Loyal is a biotechnology company developing medicines to extend dog lifespan. By developing drugs with the potential to slow the aging process, they aim to delay or prevent age-related diseases like cancer and dementia. By quantifying and regulating the processes of aging, the company aims to slow the emergence and mitigate the intensity of age-related ailments, thereby facilitating extended periods of improved health for both species.

Vahan.ai

Series A in 2021
Vanan Online Services provides Translation,Transcription, Captioning and Subtitling,Voice Over, Typing on a single platform.

Juno

Series A in 2021
Juno Residential develops apartment buildings intended to offer environment-friendly and speedy housing alternatives. It uses prefabrication techniques and organic and low-carbon materials like mass timber, thereby providing clients with modern and curated apartments.

PolyAI

Series A in 2021
PolyAI develops a machine learning platform for conversational artificial intelligence. PolyAI builds enterprise voice assistants that carry on natural conversations with customers to solve their problems. PolyAI's voice assistants understand customers, regardless of what they say or how they say it. Founded in 2017, the company has its headquarters in London, England, United Kingdom, and New York, United States of America.

Connie Health

Series A in 2021
Connie Health empowers older Americans to make confident, worry-free healthcare decisions.

IgGenix

Series A in 2021
IgGenix is a biotechnology company, directly address food and other severe allergies by re-engineering key antibodies involved in the allergic cascade. IgGenix isolates and transforms allergen-specific IgE antibodies into IgG antibodies that are designed to alleviate and possibly prevent the allergic cascade.

NetSpring

Series A in 2021
NetSpring focuses on product and customer journey analytics. They offer tools to analyze product usage, user behavior, and customer experiences across various channels. The platform is designed for modern data environments, offering warehouse-native analytics without the need for data duplication. It helps businesses prioritize feature development, optimize customer acquisition, and reduce churn by analyzing user behavior and product interaction trends.

Varda

Series A in 2021
Varda Space Industries, Inc. is a space manufacturing startup based in San Francisco, California, founded in 2020 by Delian Asparouhov and Trae Stephens. The company specializes in creating products in space that are intended for terrestrial applications, leveraging the unique advantages of low gravity. Varda aims to establish an infrastructure for harvesting materials from asteroids, enabling the production of new products in space. This approach not only facilitates the manufacturing of innovative goods but also promotes sustainability by reducing reliance on the destructive extraction of Earth's resources.

Jones

Series A in 2021
Jones is a software company that helps real estate and construction companies to remove insurance risk across every property, project, and application. We believe that real estate and construction managers in the built world can make smarter, faster decisions about risk transfer. To realize this vision, we provide our clients with software, data, and insights to unlock the intelligence for better decision making. We call it “Risk Intelligence”.

OpenStore

Series A in 2021
OpenStore connects merchants and customers into a single unified shopping experience through access to data, information, and capital. The company aims to offer instant liquidity for eCommerce entrepreneurs.
At Smile ID they believe anyone should be able to prove their identity easily, anywhere in the world. Their team is made up of American and African engineers and financial services professionals with experience across global markets in highly regulated environments. They have built encryption, authentication and security solutions. They have developed image processing technology from the chip level up. They have been part of security investigations and have pursued fraudsters. Having worked with, or for, telecoms, lenders, banks and startups, they know the challenges of building world class technology and they understand the needs of the African consumer and enterprise customer. They are backed by leading Silicon Valley & African investors and they have pan-African reach, with representation in the United States, South Africa, Nigeria, Kenya, Ghana and Rwanda.

GAIL

Series A in 2021
GAIL is a generative AI solution for insurance agencies. It provides a multilingual AI capable of communicating via speech, SMS, email, and WhatsApp. It also provides recordings, transcripts, analytics, and follows up with callers with any necessary deliverables.

Lessen

Series A in 2021
Lessen is a technologically enabled, end-to-end solution for outsourced real-estate property services that delivers consistency, quality, and speed at scale. This includes primarily single-family and multifamily rental renovations, turns, and maintenance. Through automation and real-time analytics, the company's technology suite is disrupting and modernizing a project management space that is still reliant on traditional organizational and communication models. Using its proprietary technology platform, its professional field project managers provide hands-on service and leverage a network of vetted service professionals in over 40 markets across the country.

Lexion

Series A in 2021
Lexion developed a contract management system that organizes all contracts in one place. The company's system automatically reads and interprets legal terms, policies, and documents, as well as finds and gains insights about the contracts in a unified system powered by artificial intelligence, while also integrating business, storage, and signature systems and syncing all work in an integrated contract hub, allowing businesses to save time and money while automatically tracking critical contract obligations.

Ellipsis Health

Series A in 2021
Ellipsis Health is an early-stage start-up developing affective computing for existing patient/care team interactions to create a real-time, behavioral health vital sign for each patient. It provides a simple, cost-effective way for health systems to continually screen their patient population for conditions such as depression and get patients the support they need.

Catch

Venture Round in 2021
Catch is redesigning benefits to put people at the center of their own financial stability and security. For freelancers, contractors, and workers without access to employer benefits, Catch automatically handles tax withholding, builds long-term investment savings, and provides critical insurance products. In creating a personalized safety net, Catch envisions a world where individuals can leverage data-driven curation and timely insights to gain full agency over changing needs.

Waabi

Series A in 2021
Waabi is an artificial intelligence company that develops autonomous driving technology for the transportation sector. It offers a self-driving solution known as the Waabi Driver, designed for integration with trucks and aimed at large-scale commercialization and safe deployment. The company primarily serves the logistics and transportation industries with its autonomous trucking solutions The company was founded in 2021 by Raquel Urtasun and is based in Toronto, Canada.

Docbot

Series A in 2021
Docbot is an artificial intelligence technology company focusing on gastrointestinal (GI) diseases. Docbot’s products are built on the UltivisionAI software platform for real-time image analysis, automated reporting, and analytic tools to improve patient care and clinical workflows. Docbot's mission is to provide the most powerful AI-assisted image analysis solutions to revolutionize GI care.

Fireflies.ai

Series A in 2021
Fireflies.ai develops an AI-powered solution for recording and transcribing meetings. It captures conversations and generates searchable notes. The focus is on applications in sectors such as business, education, and remote work.

Apton Biosystems

Series A in 2021
Apton Biosystems develops an optical system designed for sequencing and protein detection, using super-resolution to assess molecules spaced closer than a wavelength of light. It enables biomarker discovery, early disease detection, and therapeutic monitoring, advancing preventive health and precision medicine.

Level

Series A in 2021
Level is a technology company that makes financial products for employers. With Level, everyone benefits: employers offer bigger benefits for less, members get more freedom and choice, and providers are paid instantly. Level makes paying with benefits as simple as paying with cash. The company was founded in 2018 and is based in New York, New York.

Draft

Series A in 2021
Draft leverages the recent advances in blockchain technology to build job marketplace platform from the ground up.

Avvir

Series A in 2021
Avvir works seamlessly with its existing systems from photo capture, to construction workflow management to laser scans and 360 photos. Their platform helps them identify potential risks and slowdowns, plus save time and money by automating their progress and earned value tracking, quality control, and as-built creation.

Bionaut Labs

Series A in 2021
Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality. By creating a new medical modality of remote-controlled micro-robots called Bionauts, the company can transform the way the biopharmaceutical industry develops treatments, allowing them to engineer the therapeutic index for efficacy and maintain safety. Bionaut Labs is focused on helping patients suffering from debilitating brain diseases who have few available treatment options. The anatomical targeting capabilities of the Bionaut platform make new therapeutics technologies such as gene therapy, CRISPR-Cas9, and oncolytic viruses viable in challenging clinical settings.

Supplant

Series A in 2021
Supplant is a biotechnology platform working in the food sector. It develops natural food ingredients from agricultural resources to allow food manufacturers to decrease sugar, increase fiber, and boost the gut health-promoting qualities of its products.

Darwin Homes

Series A in 2021
Darwin Homes is the property management platform that elevates the rental experience for property owners and residents. It offering a comprehensive set of services to Owners and Residents. Darwin is committed to bringing transparency and integrity to Property Management - elevating the experience once and for all.

Earli

Series A in 2021
Earli is a developer of cancer treatment devices designed to search for natural biomarkers. The company's mission is to make cancer a benign experience. Cancers are detected early when they are homogeneous; and then located early, so they can be treated when the chances of survival are multiple times higher. Rather than rely on biomarkers that cancer may - or often may not - naturally provide, Earli's technology forces cancer cells to make a synthetic, non-human biomarker using a novel gene therapy approach called Synthetic Biopsy. The early cancer is then visible in a PET scanner. The same platform is also usable for therapeutics.

LUB Foods

Venture Round in 2021
Luthman Backlund Foods AB was started in 2013 by Carl Backlund and Niclas Luthman. Since then they have built a team of dedicated and hard-working people around us that all share the same vision - creating snacks and confectionery that is actually good for you and the people you love. THeir ambition is to create a global brand and a wide range of products that adds to the quality of life and well-being of all the snacks and candy-loving people of the world.

CloudTrucks

Series A in 2020
CloudTrucks develops a virtual trucking carrier application designed to reduce operating costs for truck drivers. The platform helps to manage and book loads from brokers and shippers, offer instant payments after load delivery, and access to cheap insurance options, enabling truck owners and operators to strategize their schedule and design a revenue-maximizing driving program. The company was founded in 2019 and is headquartered in San Francisco, California.

Akasha Imaging

Series A in 2020
Akasha Imaging is a deep imaging technology company combining computational imaging and deep learning to deliver high-resolution 3D images.

WaveOne

Series A in 2020
WaveOne is building the next generation of digital media compression. They are leveraging the latest advancements in machine learning and deep learning to create custom-tailored, context-dependent solutions.

Heyday

Series A in 2020
Heyday is a consumer-focused business that operates an online platform for brands in digital marketplaces, helping them enhance their eCommerce presence. Founded in 2020 and based in San Francisco, the company aims to support sellers in reaching new heights within the marketplace landscape. Additionally, Heyday Wellness, established in 2015 and located in New York, specializes in customized skincare services, offering tailored facial treatments that include deep cleansing, skin analysis, exfoliation, extractions, hydration, and SPF protection. The wellness segment also features a range of skincare products such as beauty creams, lotions, and wipes available through both physical stores and online channels. Together, these offerings position Heyday as a versatile player in the beauty and skincare industry.

Hermeus

Series A in 2020
Hermeus is developing Mach 5 aircraft to speed up the global transportation network. Mach 5 flight is not just supersonic, it's hypersonic. At these speeds, a flight from New York to London is 90 minutes, rather than 7 hours. Its aircraft massively reduces flight times and increases safety for the long haul and business class air travel, enabling businesses to operate with minimal changes to current aviation infrastructure. The company was founded in 2018 and headquartered in Atlanta, Georgia.
Advanced Chemotherapy Technologies is a healthcare company that is developing breakthrough combination drug-device technologies for treating pancreatic cancer.

Invoy

Series A in 2020
At Invoy, we are committed to leveraging science, data and artificial intelligence to help you reach your health and weight loss goals. Every person has a unique body chemistry and respective set of goals. Invoy strives to be at the forefront of solutions that target your individuality to enhance your performance.

Vicarious Surgical

Series A in 2020
Vicarious Surgical is a next-generation robotics company developing a disruptive technology with the goal of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs. Vicarious Surgical aims to revolutionize the field of minimally invasive surgery by developing advanced robotic systems that allow surgeons to perform complex procedures with greater precision and control. The company's robotic system is designed to be compact and portable, enabling it to be easily integrated into existing operating rooms without significant modifications. The robot's design also aims to minimize the invasiveness of surgical procedures, leading to faster patient recovery times and reduced post-operative discomfort.

IgGenix

Series A in 2020
IgGenix is a biotechnology company, directly address food and other severe allergies by re-engineering key antibodies involved in the allergic cascade. IgGenix isolates and transforms allergen-specific IgE antibodies into IgG antibodies that are designed to alleviate and possibly prevent the allergic cascade.

Cover

Series A in 2020
Cover is a technology company that designs, manufactures, and installs custom Backyard Studios. Cover’s mission is to make living in a thoughtfully designed and well-built home a reality for everyone. Using proprietary design software and a precision manufactured building system, Cover delivers exceptional design, functionality, and energy performance, in a fraction of the time of traditional custom construction. Cover has launched in Los Angeles and is taking pre-orders worldwide.

Oobli

Series A in 2020
Joywell Foods is developing the first healthy, protein sweeteners. Derived from exotic plants, protein sweeteners are rare compounds that provide an amazing taste without the calories. These proteins, produced through fermentation, have no glycemic impact and do not affect the gut microbiome. The company has received regulatory approvals, including FDA "no questions" letters and GRAS status for multiple proteins

Fernish

Series A in 2020
Fernish is a furniture rental startup company that offers provides furniture as a subscription model to consumers living a mobile lifestyle. The company seeks to redefine the way the market sees furniture rental by positioning itself as a lifestyle brand. It offers a rent to own program that allows subscribers to apply their previous payments towards the cost of the piece or pieces they want to buy at the end of their subscription. Users are allowed to subscribe to an entire room or specific pieces and can even swap out things they don’t like or simply want to change up at any point. Founders Michael Barlow and Lucas Dickey launched the company in Los Angeles, California in 2017.

Commonwealth Fusion

Series A in 2020
Commonwealth Fusion is a research company that develops energy through an inexhaustible power plant. It uses rare-earth barium copper oxide superconductor technology to develop energy. They combine proven physics backed by decades of government-funded fusion research with a revolutionary superconducting magnet technology to accelerate the path to commercial fusion energy Commonwealth Fusion Systems (CFS) is on track to bring fusion energy technology to the market. CFS was spun out of MIT and is collaborating with MIT’s Plasma Science and Fusion Center to leverage decades of research combined with the innovation and speed of the private sector. The business designs and builds fusion machines that deliver limitless and clean fusion energy and integrate proven physics with magnet technology, allowing clients to contribute to the expansion of renewable energy while mitigating the effects of climate change.

Statespace

Series A in 2020
StateSpace provides performance analytics and a suite of tools for casual gamers and esports athletes to maximize their potential. It uses cognitive science and artificial intelligence to revolutionize the way humans improve. Leveraging expertise as neuroscientists, data scientists, video game developers, and computer visionaries, the products bring much needed standardized performance analytics to train.It was founded in 2017 and is headquartered in New York, New York.

HeartVista

Series A in 2020
HeartVista is a medical technology company that provides one-click diagnostic imaging. It brought in machine learning to make the scanning process faster, easier, and more consistent. Its platform leverages existing scanners and contains all of the mri tools needed for a comprehensive cardiac examination, with just one click.

Tabnine

Series A in 2020
Tabnine is an AI coding assistant that helps development teams of every size use AI to accelerate and simplify the software development process without sacrificing privacy & security

Yes Health

Series A in 2020
Yes Health is an all-mobile diabetes prevention program designed to empower people everywhere to start living healthier, happier lives. Its team is consists of physicians, health coaches and engineers that created a high-engagement program that’s low-cost, easy to follow and successful in preventing the onset of diabetes. People already living with the disease can also use it to successfully manage their symptoms. Yes Health helps people take charge of their health—and have fun doing it—by developing healthy habits that last a lifetime. Its mission is to stop diabetes.

Sword Health

Series A in 2020
Sword Health is on a mission to free 2 billion people from pain by pioneering the field of AI Care. It is #1 in clinical and cost-saving outcomes because we have the most advanced AI, developed and overseen by the most clinically rigorous team. Sword has developed the first platform to predict, prevent, and treat pain by starting with the expertise of world-class doctors of physical therapy and then building an interactive AI experience to deliver care that members can use anywhere, anytime, under a clinician’s supervision.

Fountain Therapeutics

Series A in 2020
Fountain Therapeutics, Inc. is a biotechnology company focused on developing treatments for age-related diseases. Founded in 2018 and based in San Francisco, California, the company aims to create a future where individuals live healthier for longer. It employs a transformative cellular model that mimics the complex characteristics of aging within a laboratory setting. By integrating this model with advanced artificial intelligence and computer vision, Fountain Therapeutics seeks to establish an innovative platform for identifying novel therapeutic targets. This approach is designed to facilitate the development of effective treatments for diseases associated with aging, ultimately aiming to reverse cellular aging and improve health outcomes.

Culdesac

Venture Round in 2019
Culdesac Inc. develops and manages post-car real estate services in the United States. It offers ridesharing, bikes and scooters, and same-day grocery delivery services. Culdesac Inc. was incorporated in 2018 and is based in San Francisco, California.

Cue

Series A in 2019
Cue puts you, your interests, and your friends at the heart of the experience. Cue works with other apps and services to help you find fun things to do, and gives you the tools to easily share ideas and create events with friends.

Light Field Lab

Series A in 2019
Light Field Lab is a breakthrough technology startup that builds an innovative holographic ecosystem. It re-creates what optical physics calls a real image for off-screen projected objects by generating a massive number of viewing angles that correctly change with the point of view and location just like in the real world. They enable entirely new business opportunities across consumer and enterprise markets. The company was founded in 2017 by Jon Karafin, Brendan Bevensee, and Ed Ibe, with the single mission to enable a holographic future by building upon the founders’ collective expertise of light field technology innovation. Based in San Jose, CA, Light Field Lab is backed by top-tier venture firms including Khosla Ventures.

Ceibo

Series A in 2019
Ceibo has a unique and proprietary technology for leaching copper sulphide and has developed and deployed a set of technologies for suppressing dust in mining operations. Ceibo is currently operating in several large mining assets of some of the largest mining companies in the world.

Mighty Buildings

Series A in 2019
Mighty Buildings, Inc. is a San Francisco-based company founded in 2017 that specializes in the manufacturing of 3D printed custom homes. The company aims to disrupt the residential housing market by utilizing advanced 3D printing technology, robotics, and composite materials to create prefabricated, environmentally friendly, and climate-resilient homes. Its innovative platform is designed to make housing more affordable and accessible, addressing challenges in urban development and construction efficiency. Through its patented technology, Mighty Buildings offers smart housing solutions that prioritize sustainability and affordability in the construction industry.

Veri5Digital

Series A in 2019
Veri5Digital is a Bengaluru-based company that specializes in digital identity verification solutions, primarily focusing on KYC (Know Your Customer) processes. Founded in 2015, the company leverages artificial intelligence and machine learning to enhance verification efficiency. Its offerings include a comprehensive suite of services such as hosted solutions, eSign, eNach, and access to government and regulated systems through its enterprise SaaS platform. Additionally, Veri5Digital provides plug-and-play SDKs and APIs, allowing for seamless integration into various applications. By utilizing data analytics, the company aims to improve service delivery and reduce operational costs for its clients in both the private sector and government-related initiatives. Formerly known as Aadhar Bridge, Veri5Digital continues to play a significant role in advancing digital identity solutions in India.

Truework

Series A in 2019
Truework is a one-stop platform that helps banks, lenders, and others verify income and employment. It is used for employment and income verification which puts consumers in control of the data. It specializes in the fields of financial services, fintech, and developer APIs.

Tempo

Series A in 2019
Tempo designs and develops a home fitness platform with personal guidance to help users in their training sessions. It features live elite trainers who can help users when they make mistakes. It has built-in three-dimensional sensors that track form, counts reps, and recommend weights. It helps users to improve in real-time. Powered by 3D motion sensors and AI, it analyzes 25 of the body’s essential joints as users work out and gives understood form feedback. Moawia Eldeeb and Joshua Augustin founded it as Pivot in 2015, with its headquarters in San Francisco in California.

Akash Systems

Series A in 2019
Akash Systems specializes in the development and supply of advanced small satellite technology, including CubeSats, satellite transmitters, and RF power amplifiers. Founded in 2016 by Felix Ejeckam and Ty Mitchell and based in San Francisco, the company leverages a proprietary composite material known as gallium nitride (GaN)-on-Diamond. This innovative material enhances energy efficiency by operating at cooler temperatures, which effectively reduces the size, weight, and operating costs of their products. Akash Systems' technology minimizes waste heat generated by power amplifiers, thereby allowing clients in the aviation and aerospace industries to lower launch costs, decrease cost-per-bit, and improve communication access.

Commonwealth Fusion

Series A in 2019
Commonwealth Fusion is a research company that develops energy through an inexhaustible power plant. It uses rare-earth barium copper oxide superconductor technology to develop energy. They combine proven physics backed by decades of government-funded fusion research with a revolutionary superconducting magnet technology to accelerate the path to commercial fusion energy Commonwealth Fusion Systems (CFS) is on track to bring fusion energy technology to the market. CFS was spun out of MIT and is collaborating with MIT’s Plasma Science and Fusion Center to leverage decades of research combined with the innovation and speed of the private sector. The business designs and builds fusion machines that deliver limitless and clean fusion energy and integrate proven physics with magnet technology, allowing clients to contribute to the expansion of renewable energy while mitigating the effects of climate change.

Future

Series A in 2019
Future offers one-on-one digital training with fitness coaches, at home, at the gym, or on-the-go. Future pairs its clients with coaches who have trained pro athletes, Hollywood celebrities, and working professionals.

Sword Health

Series A in 2019
Sword Health is on a mission to free 2 billion people from pain by pioneering the field of AI Care. It is #1 in clinical and cost-saving outcomes because we have the most advanced AI, developed and overseen by the most clinically rigorous team. Sword has developed the first platform to predict, prevent, and treat pain by starting with the expertise of world-class doctors of physical therapy and then building an interactive AI experience to deliver care that members can use anywhere, anytime, under a clinician’s supervision.

Kudi

Series A in 2019
KUDI is a financial service provider focused on providing access to electronic banking and financial services by leveraging conversational interfaces, natural language processing and artificial intelligence to provider faster access, frictionless experience, and ultimately boost financial inclusion in emerging markets. KUDI is enabling secured financial transactions via Facebook, Telegram, Slack and Skype. KUDI's focus is the African market with a primary focus on the Nigerian Payment ecosystem and the company does this in partnership with e-payment regulators, a leading commercial bank, and an international payment processor.

Prellis Biologics

Series A in 2019
Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize healthcare. Prellis Biologics'​ technology leverages massive gains in print speed and resolution to break the microvasculature barrier. The company was founded in 2016 and is based in San Francisco, California.

Zendar

Series A in 2019
Zendar develops high-definition radar for autonomous vehicles. Zendar's product combines the benefits of radar, such as long-range and all-weather operation, with the resolution of lidar. It was founded in 2017 and is based in Berkeley, California.

Ellevest

Series A in 2019
Ellevest provides an engaging investing experience to help women meet their financial goals in life. Ellevest offers a modern, engaging user experience. The same care, thoughtfulness, and attention to detail that is reflected in its beautiful, easy-to-use interface are applied to the construction of its portfolios, its selection of investments, and the development of the algorithms that drive its forecasts and recommendations.

Anchorage Digital

Series A in 2019
Anchorage Digital is a regulated crypto platform that provides institutions with integrated financial services and infrastructure solutions. With the only federally chartered crypto bank in the US, as well as Anchorage Digital Singapore, which offers equivalent security and service standards, Anchorage Digital provides institutions an unparalleled combination of secure custody, regulatory compliance, product breadth, and client service. Founded in 2017, Anchorage Digital is valued at over $3 billion with funding from leading institutions including Andreessen Horowitz, GIC—Singapore’s sovereign wealth fund, Goldman Sachs, KKR, and Visa. Headquartered in San Francisco, California, Anchorage Digital is remote-friendly with offices in New York, New York; Porto, Portugal; Singapore; and Sioux Falls, South Dakota. Learn more at anchorage.com, on Twitter @Anchorage, and on LinkedIn.

Compound Eye

Series A in 2018
Compound Eye Inc develops 3D vision systems for autonomous machines.

Homebound

Series A in 2018
Homebound is a custom homebuilder that makes building the perfect home simple, transparent and human. Born out of the 2017 Northern California wildfires, Homebound was created by a local team of construction, real estate, design and technology experts who set out to create a better homebuilding solution for friends, family and neighbors affected. Homebound is the first homebuilder to manage the entire building process for homeowners and support them every step of the way — from insurance negotiation and architecture all the way to permitting, construction and move-in. Through easy-to-use technology and a network of vetted building experts, Homebound is simplifying the rebuilding process and alleviating the stress, complexity and uncertainty homeowners face after a natural disaster.

Mojo Vision

Series A in 2018
Mojo Vision is focused on developing and commercializing high-performance micro-LED display technology for consumer, enterprise, and government applications. The company combines breakthrough technology, leading display and semiconductor expertise, and an advanced 300mm manufacturing process to deliver on the promise of micro-LED displays. Mojo’s proprietary quantum-dot technology brings full-color capability to its display platform and meets the superior performance demands for all form factors. Mojo Vision developed the world’s smallest, densest dynamic display for the first AR smart contact lens and is now applying this innovation and expertise to lead the disruption of the $160 billion display industry. Mojo Vision was founded in 2015 and headquartered in Saratoga, California.

Loop Genomics

Series A in 2018
Loop Genomics is a platform technology for long-read DNA sequencing. Loop Genomics technology transforms short-read DNA sequencers into high-throughput, long-read, single-molecule DNA sequencing machines. Loop Genomics long-read DNA sequencing technology provides phased sequencing solutions across a diverse repertoire of research and clinical applications. Sequencing of partial rRNA gene sequences results in reduced phylogenetic resolution. Full-length, high-throughput, phased sequencing that covers all 16S variable regions is becoming the gold standard for profiling the microbiome. Achieve the highest resolution microbial community profiling with long-read, next-generation sequencing of the microbiome. Characterizing polymorphisms in HLA genes inside and outside of the protein-coding regions is important for organ transplantation compatibility testing and for strengthening causality association studies. The length of homologous sequences between HLA alleles extends beyond the capabilities of short-read sequencing platforms, resulting in diploid ambiguities and a reliance on imputation. Sequence full-length HLA DNA and/or RNA with phased, high throughput, long-read sequencing that resolves allelic discrimination and diploid ambiguity. Viral genetic variability is a major determinant of viral drug resistance and viral vaccine efficacy. Accurately mapping viral genetic variability is a critical step in choosing the optimal course of therapy and developing efficacious vaccines. Key mutations are typically located throughout long stretches of viral genomes, making the retrieval of critical phased data challenging using short-read sequencing technology. Use phased, high-throughput DNA sequencing technology to map key mutations at the quasi-species level and generate a complete phased map of viral populations.

Siren Care

Series A in 2018
Siren Care is engaging with providers and payers to transform healthcare for chronic disease and aging. Our flagship program, the Siren Diabetic Foot Program, is a comprehensive service powered by our proprietary Siren Socks which monitor foot temperature continuously to deliver superior early detection of diabetic foot ulcers.

Carrot

Venture Round in 2018
Pivot’s unique six-stage program is designed to engage smokers earlier than other cessation plans, without pressuring them to quit. It begins by helping them become more aware of their smoking and more confident in their ability to do something about it. Then, for those who decide they’re ready, Pivot helps them build and execute a quit plan, with one-on-one coaching support until their quit is stable.

Nebula Genomics

Series A in 2018
Nebula Genomics is a human genome sequencing and health big data company on a mission to usher in the era of genomic sequencing by building a large and trusted genomic and health data marketplace for consumers, researchers and the medical community. Using blockchain to ensure that consumers maintain control of their data and are compensated for its use, the Nebula marketplace will aggregate a critical mass of rich genetic information that researchers can analyze in order to accelerate drug development, streamline clinical trials, and usher in the era of truly personalized medicine. The company was founded by Harvard genomics pioneer George Church, along with Harvard researchers Dennis Grishin and Kamal Obbad. Founded in 2017, Nebula Genomics has offices in San Francisco, CA and Boston, MA and is backed by investors including Khosla Ventures, Arch Venture Partners, Fenbushi Capital, Mayfield, F-Prime Capital Partners, GreatPoint Ventures, Hemi Ventures and Mirae Asset.

Canary

Series A in 2018
Canary Connect, Inc. is a New York-based technology company specializing in home security systems designed to enhance safety and connectivity for users. Founded in 2012, the company offers a range of products, including the all-in-one Canary security solution, which features an HD camera, siren, and air monitor, as well as the Canary Flex, a versatile HD security camera suitable for both indoor and outdoor use. Additionally, Canary provides a web-based application, Canary Talk, which allows users to stream live video from their homes in real-time. The company focuses on delivering affordable and user-friendly smart home security solutions, catering to both renters and homeowners. Canary's products and services are available for purchase online, and they include subscription bundles that offer features such as 24/7 live video monitoring, AI-driven motion alerts, and video history, connecting homes to users' smartphones.

Scipher Medicine

Series A in 2018
Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient. The company is committed to transforming the way providers prescribe drugs, as well as the way manufacturers, develop new drugs. They are building a molecular map of all protein interactions that identifies genomic signatures and links those to disease and predictive treatment outcomes. Using a simple blood sample to analyze RNA, Scipher Medicine can predict if a patient is likely to respond to a targeted therapy before therapy is prescribed. This insight allows patients to start the most effective therapy from day one. For its first commercial product, they have developed PrismRA®, a first-of-its-kind blood test that can predict which patients with rheumatoid arthritis are less likely to respond to TNFi therapies such as Humira® and Enbrel® so that such patients can go on alternative approved drugs. Scipher Medicine is building the future of patient treatment. Most patients who are prescribed blockbuster therapies today don't respond to treatment, costing the healthcare industry billions in wasted drugs while patients continue to suffer. Scipher's platform identifies which drug will work based on the patient's fundamental disease biology, and not based on symptoms, disease classification, or medical bias. A routine blood test predicts which drug he/she will respond to, with our first product focusing on rheumatoid arthritis, ensuring that the most optimal treatment is prescribed from day one. The molecular data generated by our tests are then used to fuel novel target discovery to address a clear unmet medical need in patients who do not respond to any existing therapy.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.